ELTP- in other words, promoting is not necessary when an OTC is in development, balancing the PNL, building an awesome pipeline, assembling professional teams, contending with DEA and plenty of other red tape that businesses deal with when they are fully reporting, and them pile on top, all the bs spewing about from non-shareholders
who are constantly asking uneducated questions.
As an investor/owner, I say, "stop wasting our time with bs so we can develop the business".